Horizon Pharma (HZNP) Posts Q4 Loss of 97c/Share

Horizon Pharma (NASDAQ: HZNP) reported Q4 EPS of ($0.97), $0.20 better than the analyst estimate of ($1.17). Revenue for the quarter came in at $3.53 million versus the consensus estimate of $2.2 million.

For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Marchex (MCHX) Reports In-Line Q2 EPS
• ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c